d
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
BIAD....bio tech company worth looking into. .11$ check out the mids technology.
BIAD....bio tech company worth looking into. .11$ check out the mids technology.
Hey bob...I think you overlooked the short term investments on the balance sheet of meip..they just raised 40+ mill in December....plenty of cash and low os imo.
Still going to a dollar?
Yet they get fda fast track designation....the data was that bad...lol
Yet they get fda fast track designation....the data was that bad...lol
ONTY..volume alert...in at 1.50...
CPXX...report out. Still on track for phase 3 results this q...
report looks solid...catalyst within the coming weeks.
The 10k stated the research would be completed by end of april...didnt say the report would be released. More grant money is another positive sign...imo.
GALE....volume alert. I jumped in a couple weeks ago...this is still well below last offering at 1.57$...
CPXX...data news out. Any thoughts here??
"When fludarabine and CPX-351 were exposed to leukemia cells, intracellular concentrations of cytarabine triphosphate (Ara-CTP) were increased by two to three fold. This is important since Ara-CTP is the active form of cytarabine that kills the leukemia cells. Chk1 inhibitors and CPX-351 synergized to induce increased DNA fragmentation and apoptosis, leading to increased (as high as 10-fold) leukemia cell kill in a number of AML lines as well as in AML patient blasts.
CPXX...data news out...really solid imo.
BIAD...worth a look... $ .165. Bio with a big catalyst coming...
The Company is encouraged by the preliminary results from a proof of market study, part-funded by a UK government grant, for its novel Magnetic Immunoassay Detection System ("MIDS") technology to be based on the Company's existing intellectual property. A follow-on grant application, relating to a MIDS feasibility evaluation, was made on March 25, 2015, and, if successful, further grant applications are expected to be made as MIDS moves through its development program.
BIAD...worth a look... $ .165. Bio with a big catalyst coming...
The Company is encouraged by the preliminary results from a proof of market study, part-funded by a UK government grant, for its novel Magnetic Immunoassay Detection System ("MIDS") technology to be based on the Company's existing intellectual property. A follow-on grant application, relating to a MIDS feasibility evaluation, was made on March 25, 2015, and, if successful, further grant applications are expected to be made as MIDS moves through its development program.
BIAD. $ .165. Bio with a big catalyst coming...
The Company is encouraged by the preliminary results from a proof of market study, part-funded by a UK government grant, for its novel Magnetic Immunoassay Detection System ("MIDS") technology to be based on the Company's existing intellectual property. A follow-on grant application, relating to a MIDS feasibility evaluation, was made on March 25, 2015, and, if successful, further grant applications are expected to be made as MIDS moves through its development program.
BIAD. $ .165. Bio with a big catalyst coming...
The Company is encouraged by the preliminary results from a proof of market study, part-funded by a UK government grant, for its novel Magnetic Immunoassay Detection System ("MIDS") technology to be based on the Company's existing intellectual property. A follow-on grant application, relating to a MIDS feasibility evaluation, was made on March 25, 2015, and, if successful, further grant applications are expected to be made as MIDS moves through its development program.
What says BIAD hired them? ...The UK paid for it according to what I am reading...
BIAD...worth a look...bio stocks are hot!...big ihub names are in...cash on hand...no debt...catalysts lined up!
BIAD...worth a look...bio stocks are hot!...big ihub names are in...cash on hand...no debt...catalysts lined up!
BIAD...bio stocks are hot!...big ihub names are in...cash on hand...no debt...catalysts lined up!
BIAD...bio stocks are hot!...big ihub names are in...cash on hand...no debt...catalysts lined up!
Any thoughts on the trading action...shorting?...been trying to watch level two when I can...
I think the article from today is a little off...I am tracking two data releases by 30 june....
any thoughts here on GALE? two q2 catalysts...not the big one though. just had an offering at 1.56...
sure did, bought more biad and jumped back in imnp...watching idra.
Added more today.
Biad...worth looking into...
Biad....bio stock that is set to move north.
Good to see this...
Good to see no reverse split....again....step in the right direction imo.
Any thoughts on where they will get some cash to continue?
Nice buys rolling in...
Nope...but going to watch for now...need to see where funds are going to come from...
Well...glad u sold after the 10k was released. What form is the new dilution going to take now that they are out of cash? Pending s1 also per the report...
Would love to see those emails.
Ill say I got fooled when this happened last year and zoomed up over a dollar. I thought it was stuck and got out. 65 mil in cash...increasing volume...good times will come this year. They may be tapping the atm...but it is running low imo.
That would have been awesome...but that can't happen. I just questioned what the f is going on...especially with the reported revs. Seems to me like we have to wait out the end of the toxic financing...kind of like ec-g....imo
I started buying today. Talked to the ceo via email...dilution will end.
#dollarbound!